R&D Mosquitoes, malaria, and UK R&D viral disease vaccine invest... The UK must sustain investment in malaria R&D as it faces a “perfect storm” of challenges, including mosquito resistance to existing tools.
News Viral disease-carrying Aedes mosquito 'breeding in London' Invasive Aedes mosquitoes and their larvae have been found in London, but the UKHSA says the risk to the public from diseases they can carry is low.
News FDA approves Roche's Zika blood test Test was first developed to screen blood supplies in Puerto Rico
News Abbott’s Zika blood test approved for emergency use Abbott's test is now the first to receive FDA commercial authorisation in an emergency use setting.
News More calamity for Theranos as it withdraws Zika test submiss... Concerns over collection of test's supporting data.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.